|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Safety and immu- nogenicity of a meningococcal B bivalent rLP2086 vaccine in healthy toddlers aged 18-36 months: a phase 1 randomized-con- trolled clinical trial显示文摘 | Marshall HS Richmond PC Nissen MD | 2012 | Pediatr Infect Dis J2012，31，10： | 1 |
| 2 | Immunomodulation via novel use of TLR4 by the filarial nematode phosphoryl choline-containing secreted product, ES-62 显示文摘 | Goodridge HS Marshall FA Else KJ | 2005 | J Immunol2005，174，1： | 1 |
| 3 | Immunomodulationvia novel use of TLR4 by the filarial nematode phosphoryicholine-containing secreted product,ES-62显示文摘 | Goodridge HS Marshall FA Else KJ | 2005 | J Immunol2005，174，： | 1 |
| 4 | Risk factors for early angle-closure disease in a Burmese population:the Meiktila Eye Study显示文摘 | Casson RJ Marshall D Newland HS | 2009 | Eye (Lond)2009，23，： | 1 |
| 5 | Dickkopf-I as a potential therapeutic target in Paget's disease of bone显示文摘 | McCarthy HS Marshall MJ | 2010 | Expert Opin Ther Targets2010，14，2： | 1 |
| 6 | Safety and immunogenielty of a meningoeoeeal B bivalent rLP2086 vac- cine in healthy toddlers aged 18-36 months, a phase 1 ran- domized-controlled clinical trial 显示文摘 | Marshall HS Richmond PC Nissen MD | 2012 | Pediatr Infect Dis J2012，31，： | 1 |
| 7 | Factors associated with HPV vaccine uptake in teenage girls, a systematic review 显示文摘 | Kessels S J Marshall HS Watson M Braunack-Mayer A J Reuzel R Tooher RL | 2012 | Vaccine2012，30，24： | 1 |
| 8 | Immunomodulation via novel use of TLR4 by the filarial nematode phosphoryl- choline-containing secreted product, ES-62 显示文摘 | Goodridge HS Marshall FA Else KJ | 2005 | J Immunol2005，174，1： | 1 |
| 9 | Safety and im- munogenicity of a meningococcal B bivalent rLP2086 vaccine in healthy toddlers aged 18-36 months: a phase 1 randomized-con- trolled clinical trial 显示文摘 | Marshall HS Richmond PC Nissen MD | 2012 | Pediatr Infect Dis J2012，31，10： | 1 |
| 10 | A bivalent Neisseria meningitidis recombinant lipidated factor H binding protein vaccine in young adults:results of a randomised,controlled,dose-escalation phase Ⅰ trial显示文摘 | Richmond PC Nissen MD Marshall HS | 2012 | Vaccine2012，30，43： | 1 |
| 11 | Safety and immunogenicity of a meningococcal B bivalent rLP2086 vaccine in healthy toddlers aged 18-36 months:a phase Ⅰ randomizedcontrolled clinical trial显示文摘 | Marshall HS Richmond PC Nissen MD | 2012 | Pediatr Infect Dis J2012，31，10： | 1 |
| 12 | Safety,immunogenicity,and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents:a randomised,single-blind,placebo-controlled,phase 2 trial显示文摘 | Richmond PC Marshall HS Nissen MD | 2012 | Lancet Infect Dis2012，12，8： | 1 |
| 13 | A phase 2 openlabel safety and immunogenicity study of a meningococcal B bivalent rLP2086 vaccine in healthy adults显示文摘 | Marshall HS Richmond PC Nissen MD | 2013 | Vaccine2013，31，12： | 1 |
| 14 | Dickkopf-1 as a potential therapeu- tic target in Paget's disease of bone 显示文摘 | McCarthy HS Marshall MJ | 2010 | Expert Opin Ther Tar- gets2010，14，2： | 1 |
| 15 | Safety and irrgramogenicity of a meningococcal B bivalent rLg2086 vaccine in healthy toddlers aged 18-36 months: a phase 1 randomized-controlled clinical trial 显示文摘 | Marshall HS Richmond PC Nissen MD | 2012 | Pediatr Infect Disease J2012，31，10： | 1 |
| 16 | Safety, immunogenicity, and tohrability of mertingococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 tfial显示文摘 | Richmond PC Marshall HS Nissen MD | 2012 | Lancet Infect Dis2012，12，8： | 1 |
| 17 | A bivalent Neisseria meningitidis recombinant lipidated factor H binding protein vaccine in young adults : results of a randomised, controlled, dose-escalation phase 1 trial显示文摘 | RichmondI PC Nissen MD Marshall HS | 2012 | Vaccine2012，30，43： | 1 |
| 18 | A phase 2 open-label safety and immunogenieity study of a meningococeal B bivalent rLP2086 vaccine in healthy adults 显示文摘 | Marshal HS Richmond PC Nissen MD | 2013 | Vaccine2013，31，12： | 1 |
| 19 | In vivo exposure of murine dendritic cell and macrophage bone marrow progenitors to the phosphorylcholine-containing filarial nematode glycoprotein ES-62 polarizes their differentiation to an anti-inflammatory phenotype显示文摘 | Goodridge HS Marshall FA Wilson EH | | 0，，04： | 1 |
| 20 | Chronic treadmill training reduces acute anxiety-related behaviors in rats显示文摘 | Fulk LJ Stock HS Marshall JD | 2003 | Int J Sports Med2003，24，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员